An Intergroup Randomised Trial of Rituximab Versus a Watch and Wait Strategy in Patients With Advanced Stage, Asymptomatic, Non-Bulky Follicular Lymphoma
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 17 Jun 2018
At a glance
- Drugs Rituximab (Primary)
- Indications Follicular lymphoma
- Focus Registrational; Therapeutic Use
- 17 Jun 2018 Long term results of the quality of life sub-study, presented at the 23rd Congress of the European Haematology Association.
- 14 Nov 2016 Planned End Date changed from 1 Oct 2011 to 1 May 2022.
- 06 Dec 2010 Preliminary results will be reported at ASH 2010.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History